Alurar rigakafin kyanda

Alurar rigakafin kyanda na kare kariya daga kamuwa da cutar kyanda .  Kusan duk waɗanda ba su haɓaka rigakafi ba bayan kashi ɗaya suna haɓaka ta bayan kashi na biyu.  Lokacin da adadin allurar rigakafi a cikin jama'a ya fi kashi 92%, barkewar cutar kyanda yawanci ba ya faruwa; duk da haka, suna iya sake faruwa idan adadin rigakafin ya ragu.  Tasirin maganin yana ɗaukar shekaru masu yawa.  Ba a sani ba idan ya zama ƙasa da tasiri akan lokaci.  Hakanan maganin na iya yin kariya daga cutar kyanda idan aka ba shi cikin kwanaki biyu bayan kamuwa da cutar kyanda.    

Gabaɗaya maganin yana da lafiya, har ma ga waɗanda suka kamu da cutar kanjamau . World Health Organization (April 2017). "Measles vaccines: WHO position paper – April 2017" (PDF). Weekly Epidemiological Record. 92 (17): 205–27. hdl:10665/255377. PMID 28459148. Archived (PDF) from the original on 23 January 2023. Retrieved 23 September 2020.  Yawancin yara ba sa fuskantar wani illa;  wadanda ke faruwa yawanci suna da laushi, irin su zazzabi, kurji, zafi a wurin allura, da taurin haɗin gwiwa; kuma gajere ne.   An rubuta anaphylaxis a cikin kusan lokuta 3.5-10 a kowace allurai miliyan.  Adadin ciwon Guillain-Barré, Autism da cututtukan hanji mai kumburi ba sa alama an ƙara su ta hanyar rigakafin kyanda.  

Ana samun maganin alurar riga kafi da kanta kuma a cikin haɗuwa kamar maganin MMR (haɗuwa tare da rigakafin rubella da maganin mumps ) World Health Organization (April 2017). "Measles vaccines: WHO position paper – April 2017" (PDF). Weekly Epidemiological Record. 92 (17): 205–27. hdl:10665/255377. PMID 28459148. Archived (PDF) from the original on 23 January 2023. Retrieved 23 September 2020. ko maganin MMRV (haɗin MMR tare da maganin kaji ).   Maganin cutar kyanda yana da tasiri daidai gwargwado don hana cutar kyanda a cikin dukkan hanyoyin da aka tsara, amma illar illa sun bambanta ga haɗuwa daban-daban.   Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar a ba da allurar rigakafin cutar kyanda a cikin watanni tara a sassan duniya da cutar ta yadu, ko kuma a watanni goma sha biyu inda cutar ba ta da yawa.   Maganin cutar kyanda ya dogara ne akan nau'in cutar kyanda mai rai amma rauni .  Yana zuwa ne a matsayin busasshen foda wanda ake hadawa da wani ruwa na musamman kafin a yi masa allura ko dai a karkashin fata ko a cikin tsoka.  Tabbatar da cewa maganin yana da tasiri ana iya tantance shi ta gwajin jini. 

An fara gabatar da rigakafin cutar kyanda a 1963.  A waccan shekarar, cutar kyanda ta Edmonston-B ta zama maganin rigakafi ta John Enders da abokan aiki kuma sun ba da lasisi a Amurka.   A cikin 1968, Maurice Hilleman da abokan aiki sun samar da ingantaccen rigakafin cutar kyanda har ma da rauni, kuma an fara rarraba shi, ya zama kawai maganin cutar kyanda da aka yi amfani da shi a Amurka tun 1968.    Kimanin kashi 86% na yara a duniya sun sami aƙalla kashi ɗaya na maganin alurar riga kafi kamar na 2018.  A cikin 2021, aƙalla ƙasashe 183 sun ba da allurai biyu a cikin jadawalin rigakafi na yau da kullun.  Yana cikin Jerin Mahimman Magunguna na Hukumar Lafiya ta Duniya .  Kamar yadda barkewar cutar cikin sauƙi a cikin al'ummomin da ba a yi wa allurar rigakafi ba, ana ganin rashin yaɗuwar cututtuka azaman gwajin isassun allurar rigakafi a tsakanin al'umma. 

 Tasiri 
alt=Measles cases 1938-1964 follow a highly variable epidemic pattern, with 150,000-850,000 cases per year. A sharp decline followed introduction of the vaccine in 1963, with fewer than 25,000 cases reported in 1968. Outbreaks around 1971 and 1977 gave 75,000 and 57,000 cases, respectively. Cases were stable at a few thousand per year until an outbreak of 28,000 in 1990. Cases declined from a few hundred per year in the early 1990s to a few dozen in the 2000s.|thumb| An ba da rahoton bullar cutar kyanda a Amurka kafin da kuma bayan gabatar da maganin.
Kashi ɗaya yana da kusan kashi 93% yana tasiri yayin da allurai biyu na allurar rigakafi kusan kashi 97% ke da tasiri wajen hana cutar kyanda. "About Measles Vaccination | Vaccination and Immunizations | CDC". www.cdc.gov. 9 January 2020. Archived from the original on 27 April 2020. Retrieved 30 April 2020. Kafin yin amfani da rigakafin cutar kyanda, cutar kyanda ta zama ruwan dare wanda har ana daukar kamuwa da cuta "kamar makawa kamar mutuwa da haraji."  A cikin Amurka, an ba da rahoton bullar cutar kyanda daga 3 zuwa miliyan 4 tare da mutuwar 400 zuwa 500 zuwa dubun dubbai a kowace shekara bayan gabatar da allurar rigakafin kyanda guda biyu a cikin 1963 (dukkanin da ba a kunna ba da kuma maganin rigakafi mai rai (Edmonston B iri). ) an ba su lasisi don amfani, duba ginshiƙi a dama).   Ƙara yawan maganin alurar riga kafi bayan barkewar cutar a cikin 1971 da 1977 ya kawo wannan ga dubban lokuta a kowace shekara a cikin 1980s. Barkewar cutar kusan 30,000 a cikin 1990 ya haifar da sabunta turawa don yin rigakafi da ƙari na rigakafi na biyu zuwa jadawalin da aka ba da shawarar. Ba a sami rahoton bullar cutar sama da 220 a kowace shekara daga 1997 zuwa 2013 ba, kuma an yi imanin cewa cutar ba ta da yawa a Amurka.    A cikin 2014, an sami rahoton shari'o'i 667. 

Amfanin allurar rigakafin kyanda a cikin rigakafin cututtuka, nakasa, da mutuwa an rubuta su sosai. A cikin shekaru 20 na farko na samun lasisi a Amurka, rigakafin cutar kyanda ya hana kimanin mutane miliyan 52 na cutar, lokuta 17,400 na nakasa hankali, da kuma mutuwar 5,200.  Daga 1999 zuwa 2004 dabarar da WHO da UNICEF suka jagoranta ta haifar da ingantuwar rigakafin cutar kyanda wanda ya kawar da kiyasin mutuwar cutar kyanda miliyan 1.4 a duniya.  Maganin rigakafin cutar kyanda ya haifar da kusan kawar da cutar a Amurka da sauran kasashen da suka ci gaba.  Yayin da aka yi maganin alurar riga kafi da kwayar cuta mai rai wanda zai iya haifar da illa, waɗannan sun yi ƙanƙanta kuma ba su da tsanani fiye da rashin lafiya da mutuwar cutar kyanda da kanta; illa masu kama daga rashes zuwa, da wuya, jujjuyawa, suna faruwa a cikin ƙaramin adadin masu karɓa.

Alurar rigakafin kyanda ya kawar da mutuwar mutane miliyan 57 tsakanin 2000 zuwa 2022, kamar yadda rahoton Hukumar Lafiya ta Duniya ya nuna. 

Cutar kyanda ta zama ruwan dare gama duniya. Ko da yake an sanar da kawar da ita daga Amurka a shekara ta 2000, ana buƙatar yawan allurar rigakafi da kyakkyawar sadarwa tare da waɗanda suka ƙi yin rigakafi don hana barkewar cutar da kuma ci gaba da kawar da cutar kyanda.  Daga cikin kararraki 66 na cutar kyanda da aka ruwaito a Amurka a cikin 2005, sama da rabi an danganta su ga wani matashin da ba a yi masa allurar rigakafi ba wanda ya kamu da cutar yayin ziyarar Romania.  Wannan mutumin ya koma wata al'umma tare da yara da yawa da ba a yi musu rigakafi ba. Sakamakon bullar cutar ta kama mutane 34, galibi yara kuma kusan dukkansu ba a yi musu allurar ba; uku daga cikinsu suna asibiti. Amsar lafiyar jama'a ta buƙaci yin kusan kiran waya 5,000 a zaman wani ɓangare na tuntuɓar tuntuɓar, tsarawa da yin gwaji kamar yadda ake buƙata, da kuma shirya rigakafin gaggawa ga mutanen da ke cikin haɗarin da suka yi hulɗa da wannan mutumin.  Masu biyan haraji da ƙungiyoyin kiwon lafiya na gida wataƙila sun biya sama da dalar Amurka 167,000 a cikin farashi kai tsaye don ɗaukar wannan barkewar.  An kawar da wata babbar annoba saboda yawan allurar rigakafi a cikin al'ummomin da ke kewaye. 

Alurar rigakafin ba ta da takamaiman tasiri kamar hana kamuwa da cututtukan numfashi, wanda zai iya girma fiye da na rigakafin kyanda kaɗai.  Waɗannan fa'idodin sun fi girma idan an ba da maganin kafin shekara ɗaya.  Alurar riga kafi ya haifar da mummunan sakamako a cikin 'yan mata, saboda haka Hukumar Lafiya ta Duniya ba ta ba da shawarar ba. 

Amsar rigakafin rigakafi ga rigakafin kyanda na iya lalacewa ta kasancewar cututtukan cututtuka irin su helminthiasis . 

 Jadawalin 
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar allurai biyu na alluran rigakafi ga duk yara. World Health Organization (April 2017). "Measles vaccines: WHO position paper – April 2017" (PDF). Weekly Epidemiological Record. 92 (17): 205–27. hdl:10665/255377. PMID 28459148. Archived (PDF) from the original on 23 January 2023. Retrieved 23 September 2020. A cikin ƙasashe masu haɗarin kamuwa da cuta ya kamata a ba da kashi na farko a kusan watanni tara.  In ba haka ba za a iya ba da shi a cikin watanni goma sha biyu.  Ya kamata a ba da kashi na biyu aƙalla wata ɗaya bayan kashi na farko.  Ana yin wannan sau da yawa a cikin shekaru 15 zuwa watanni 18.  Bayan kashi daya a cikin watanni tara 85% na rigakafi, yayin da kashi a watanni goma sha biyu yana haifar da kashi 95% na rigakafi. 

A cikin Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta ba da shawarar cewa yara masu shekaru shida zuwa watanni goma sha ɗaya da ke balaguro zuwa Amurka su sami kashi na farko na rigakafin MMR kafin tashi   sannan su sami ƙarin allurai biyu; daya a watanni 12-15 (watanni 12 ga yara a wuraren da ke da haɗari) kuma na biyu a farkon makonni huɗu bayan haka.   In ba haka ba ana ba da kashi na farko a cikin watanni 12-15 kuma na biyu a shekaru 4-6. 

A Burtaniya, Shawarar Ma'aikatar Kiwon Lafiya ta Kasa (NHS) ita ce kashi na farko a kusan watanni 13 da haihuwa kuma na biyu a shekara uku da wata hudu.  

A Kanada, Lafiyar Kanada ta ba da shawarar cewa yaran da ke tafiya a wajen Arewacin Amurka su sami rigakafin MMR idan sun kai watanni shida zuwa 12. Koyaya, bayan yaron ya cika watanni 12 yakamata su sami ƙarin allurai biyu don tabbatar da kariya mai dorewa. 

 Tasiri mara kyau 
Mummunan illa da ke hade da maganin rigakafi na MMR sun hada da zazzabi, rash, ciwon wurin allura da kuma, a lokuta da yawa, launin ja ko shunayya a kan fata da aka sani da thrombocytopenic purpura, ko ciwon da ke da alaka da zazzaɓi ( zazzaɓi ).  

Yawancin karatu ba su sami dangantaka tsakanin rigakafin MMR da Autism ba.

 Contraindications 
Ba shi da kyau ga wasu mutane su karɓi maganin kyanda ko MMR, gami da lokuta na:

 Ciki: Kada a ba mata masu ciki allurar MMR da abubuwan da ke cikinsa.  Matan da suka kai shekarun haihuwa su tuntubi likitansu game da yin allurar riga-kafi kafin su dauki ciki. "MMR Vaccination | What You Should Know | Measles, Mumps, Rubella | CDC". www.cdc.gov. 24 December 2019. Archived from the original on 26 April 2020. Retrieved 30 April 2020.
 Yaran da ke kamuwa da cutar HIV, waɗanda za su iya samun rigakafin cutar kyanda idan adadin CD4+ lymphocyte ɗin su ya fi 15%.
 Rashin raunin garkuwar jiki saboda HIV/AIDS ko wasu jiyya 
 Samun iyaye ko ɗan'uwa tare da tarihin matsalolin rigakafi 
 Yanayin da ke sa majiyyaci rauni ko zubar jini cikin sauƙi 
 Karan jini ko samfuran jini na baya-bayan nan 
 Tarin fuka 
 Karbar wasu alluran rigakafi a cikin makonni 4 da suka gabata 
 Matsakaici ko rashin lafiya mai tsanani. Koyaya, rashin lafiya mai sauƙi (misali, mura na gama gari) yawanci ba a hana shi ba. 

 Tarihi 
John Franklin Enders, wanda ya raba lambar yabo ta Nobel a fannin likitanci na 1954 don aiki kan cutar shan inna, ya aika Thomas C. Peebles zuwa makarantar Fay a Massachusetts, inda aka fara barkewar cutar kyanda; Peebles ya iya ware kwayar cutar daga samfurin jini da kuma swabs na makogwaro, kuma daga baya ya sami damar noma kwayar cutar tare da nuna cewa ana iya yada cutar ga birai da kayan da ya tattara. Martin D (4 August 2010). "Dr. Thomas C. Peebles, Who Identified Measles Virus, Dies at 89". The New York Times. Archived from the original on 6 April 2020. Retrieved 11 February 2017. Enders ya sami damar yin amfani da kwayar cutar da aka noma don samar da rigakafin cutar kyanda a cikin 1963 ta hanyar attenuation ta hanyar al'adar kaji fibroblasts na kayan da Peebles ke ware.  

A ƙarshen 1950s da farkon 1960, kusan ninki biyu na yara sun mutu daga cutar kyanda kamar na polio.  Alurar rigakafin Enders ta samo asali ne daga nau'in cutar kyanda mai rai na Edmonston, wanda aka sanya wa suna David Edmonston mai shekaru 11, dalibin Fay wanda Peebles ya dauki al'adar da ta haifar da noman cutar. 

A tsakiyar karni na 20, cutar kyanda ta yi kamari a yammacin Afirka, inda yawan mace-macen yara ya kai kashi 50 cikin 100 kafin su cika shekaru biyar, kuma yaran sun kamu da nau'in kurji da sauran alamomin da aka saba gani kafin 1900 a Ingila da wasu kasashe. , Najeriya;  idan za a iya zarge shi da cin zarafin al'ummar Najeriya, Morley ya hada 'ya'yansa hudu a cikin binciken. Sakamakon karfafa gwiwa ya kai ga yin nazari na biyu na kimanin yara 450 a kauyen da kuma asibitin Wesley Guild da ke Ilesha.

Bayan wata annoba, an gudanar da gwaji mafi girma a cikin Satumba da Oktoba 1962, a cikin New York City tare da taimakon WHO: Yara 131 sun sami rai mai rai na Enders-attenuated Edmonston B da gamma globulin, yara 130 sun sami "ƙarin ragewa" rigakafin. ba tare da gamma globulin ba, kuma yara 173 sun zama batutuwa masu sarrafawa na ƙungiyoyin biyu. Kamar yadda kuma aka nuna a gwajin da aka yi a Najeriya, gwajin ya tabbatar da cewa maganin “wanda aka kara ragewa” ya fi allurar Edmonston B, kuma ya haifar da karancin zazzabi da gudawa. Yara 2,000 a yankin an yi musu allurar rigakafin da aka kara ragewa. 

Maurice Hilleman a Merck &amp; Co., majagaba a cikin ci gaban alurar riga kafi, ya samar da ingantacciyar sigar rigakafin cutar kyanda a cikin 1968 kuma daga baya rigakafin MMR a 1971, wanda ke yin rigakafin cutar kyanda, mumps da rubella a cikin harbi guda tare da mai haɓakawa. . CDC (5 November 2020). "History of Measles". Centers for Disease Control and Prevention. Archived from the original on 6 April 2020. Retrieved 9 February 2021. Ana kiran nau'i ɗaya "Attenuvax".  Bangaren kyanda na maganin rigakafin MMR yana amfani da Attenuvax,  wanda aka girma a cikin al'adar mahaifar kaji ta amfani da nau'in Edmonston da aka rage ta Enders.  Biye da shawarwarin ACIP, Merck ya yanke shawarar kada ya ci gaba da samar da Attenuvax a matsayin maganin rigakafi a kan 21 Oktoba 2009. 

Wani bincike na 2022 a cikin Mujallar Tattalin Arziki ta Amurka ya gano cewa ɗaukar rigakafin cutar kyanda ya haifar da haɓakar samun kuɗin shiga na kashi 1.1 cikin ɗari da kuma tasiri mai kyau akan aikin yi saboda yawan samarwa da waɗanda aka yiwa alurar riga kafi. 

 Nau'ukan 
Ba safai ake ba da kyanda a matsayin mutum na alurar riga kafi kuma ana ba da shi a hade tare da rubella, mumps, ko varicella (kaza) alurar riga kafi. World Health Organization (April 2017). "Measles vaccines: WHO position paper – April 2017" (PDF). Weekly Epidemiological Record. 92 (17): 205–27. hdl:10665/255377. PMID 28459148. Archived (PDF) from the original on 23 January 2023. Retrieved 23 September 2020. A ƙasa akwai jerin alluran rigakafin da ke ɗauke da kyanda:

 Alurar rigakafin kyanda (alurar riga kafi)
 Cutar kyanda da rubella hade maganin alurar riga kafi ( MR )
 Mumps, kyanda da rubella hade maganin rigakafi ( MMR alurar riga kafi ) "M-M-R II- measles, mumps, and rubella virus vaccine live injection, powder, lyophilized, for suspension". DailyMed. 24 September 2019. Archived from the original on 6 April 2020. Retrieved 29 January 2020.  
 Mumps, kyanda, rubella da varicella hade maganin alurar riga kafi (MMRV ) "ProQuad- measles, mumps, rubella and varicella virus vaccine live injection, powder, lyophilized, for suspension". DailyMed. 26 September 2019. Archived from the original on 6 April 2020. Retrieved 29 January 2020.

 Al'umma da al'adu 
Yawancin tsare-tsaren inshora na kiwon lafiya a Amurka suna biyan kuɗin alluran rigakafi, kuma Shirin Alurar rigakafi na Yara na iya taimakawa waɗanda ba su da ɗaukar hoto.  Dokar jiha tana buƙatar yin alluran rigakafi ga yaran makaranta, amma tana ba da keɓe don dalilai na likita wasu lokuta saboda dalilai na addini ko falsafa.  Duk jihohi hamsin suna buƙatar allurai biyu na rigakafin MMR a shekarun da suka dace.  Rarraba allurar rigakafi daban-daban a cikin yanki guda ta shekaru ko ajin zamantakewa na iya ayyana mabambantan hasashe daban-daban na ingancin rigakafin. 

 Kara karantawa 






 Hanyoyin haɗi na waje 



 Measles Vaccine at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

 Manazarta 

Rukuni:Rigakafi
Rukuni:Shafuka masu fassarorin da ba'a duba ba